Skip to main content
NIH funding notice PA-18-917

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Closed on September 7, 2021.

Posted
September 10, 2018
Close date
September 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,661,719 in first-year total cost, median $663,415.

Most frequent study sections

  1. Addiction Risks and Mechanisms Study Section[ARM]2
  2. Somatosensory and Pain Systems Study Section[SPS]2
  3. Behavioral Medicine, Interventions and Outcomes Study Section[BMIO]1
  4. Special Emphasis Panel[ZRG1 HDM-A (90)]1
  5. Special Emphasis Panel[ZRG1 IFCN-B (02)]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1
  3. QUEEN'S MEDICAL CENTER1
  4. UNIVERSITY OF COLORADO1
  5. UNIVERSITY OF FLORIDA1
Competing awards under PA-18-917 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study1R01CA270483-01ASHARE, REBECCAMEGHANI, SALIMAH H.WORSTER, BROOKEUNIVERSITY OF PENNSYLVANIA, PA$699,429ZRG1
2022Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids1R01DA053332-01A1AROUT, CAROLINE AHANEY, MARGARETNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY$678,240ARM
2021Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation1R01DA053316-01GILMAN, JODILOGGIA, MARCO LUCIANOMASSACHUSETTS GENERAL HOSPITAL, MA$753,349BMIO
2021Modulation of pain mechanisms by cannabis-derived phytochemicals.1R01AT011162-01A1MACKIE, KENNETHPENNER, REINHOLDQUEEN'S MEDICAL CENTER, HI$663,415ZRG1
2020Novel Approaches to Opiate Use Reduction1R01DA048069-01A1HUTCHISON, KENT E.UNIVERSITY OF COLORADO, CO$640,563ARM
2020Opioid and cannabinoid interactions in pain and reward1R01DA049470-01A1CAUDLE, ROBERT MNEUBERT, JOHN KUNIVERSITY OF FLORIDA, FL$615,440SPS
2020Cannabinoid interactions with central and peripheral pain mechanisms in osteoarthritis of the knee1R01AT010381-01A1HARRIS, RICHARD EHARTE, STEVEN EDWARDUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$611,283SPS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-917: Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) | ScienceDex | ConductScience